28
Sep

Cervical and endometrial cancer patients report fewer side effects and better quality of life with IMRT

Results of international, ed multi-center trial focus on patient-reported outcomes for bowel and urinary side effects and health-related quality of life

Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), pills   according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO). Women receiving IMRT reported significantly fewer bowel and bladder problems than those receiving conventional radiation treatment.

Many women diagnosed with cervical or endometrial cancer receive RT following surgery to remove their tumors, but questions remain as to which form of pelvic RT delivery can most effectively eliminate the tumor while minimizing the impact of radiation on surrounding healthy tissue. This multi-center, international study assessed this impact by evaluating patient-reported acute toxicities in the gastrointestinal (GI) and genitourinary (GU) systems following IMRT, an advanced form of external beam RT that delivers precise radiation doses highly tailored to patients’ individual tumors, versus standard four-field RT.

Read Full Article Here >>